If you’re not careful, you can easily misread a label. This will affect your blood sugar, your weight, and bolus rate. Read the info in the box labeled Nutrition Facts. There are four large muffins in this container, however, you are only supposed to eat a half of a muffin per meal. This is an excellent rule of thumb for nondiabetics as well. You still make insulin. When you eat, your brain signals the pancreas to deliver insulin found in the Beta cells depending on your blood sugar, and what you eat. If you haven’t eaten and your blood sugar drops, your brain signals the pancreas to release reserved sugar located in the Alpha cells to prevent fatigue. Overworking either cell can cause havoc on the body.
Half muffin is 24 carbs. (Note- Always subtract fiber from total carbs that are 5 grams and higher) 24 carbs-6 grams of fiber= 18 carbs.
The fiber in food that is 5 g or high is not digested. Therefore you subtract it. If you don’t you will miscalculate your insulin dosage and have unexplained low blood sugars and increased weight gain.
A balanced breakfast would be:
1/2 muffin (18 carbs)
1 c. plain yogurt or milk (15 carbs)
1 egg (0 carbs)
2 sm turkey sausages ( Note: you might have to bolus for a veggie sausage. Read carb count)
1/2 fruit of your choice (11-15 carbs)
Insulin is a hormone that’s produced in the pancreas and carries glucose (foods that converts into sugar) from the bloodstream and into the cell for later use. Those that make little or no insulin have diabetes.
Afrezza (the size of a Key) is an inhalation insulin that has just been approved by the FDA. It cannot be used by those that smoke or have COPD.
Excerpt from FDA.gov
“Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal…
The drug’s safety and effectiveness were evaluated in a total of 3,017 participants–1,026 participants with type 1 diabetes and 1,991 patients with type 2 diabetes. The efficacy of mealtime Afrezza in adult patients with type 1 diabetes patients was compared to mealtime insulin aspart (fast-acting insulin), both in combination with basal insulin (long-acting insulin) in a 24 week study… Afrezza is not a substitute for long-acting insulin. Afrezza must be used in combination with long-acting insulin in patients with type 1 diabetes, and it is not recommended for the treatment of diabetic ketoacidosis, or in patients who smoke.
Afrezza has a Boxed Warning advising that acute bronchospasm has been observed in patients with asthma and chronic obstructive pulmonary disease (COPD). Afrezza should not be used in patients with chronic lung disease, such as asthma or COPD because of this risk. The most common adverse reactions associated with Afrezza in clinical trials were hypoglycemia, cough, and throat pain or irritation…”
https://www.youtube.com/watch?v=GGgGjtM5ipg See how it works
https://www.youtube.com/watch? v=TkJ10Nq1xmM&utm_source=streamsend&utm_medium=email&utm_content=23104289&utm_campaign=TCOYD&%23×27;s%20January%20EUpdate The History of the inhaler and how it was scaled down in size